Cited by 209Psychedelics and Drug StudiesMindfulness and Compassion InterventionsReligion, Spirituality, and Psychology

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities

Soler, Joaquim, Elices, Matilde, Franquesa, Alba, Barker, Steven, Friedlander, Pablo, Feilding, Amanda, Pascual, Juan C., Riba, Jordi·2016·Psychopharmacology

Abstract

Background Ayahuasca is a psychotropic plant tea used for ritual purposes by the indigenous populations of the Amazon. In the last two decades, its use has expanded worldwide. The tea contains the psychedelic 5-HT2A receptor agonist N,N-dimethyltryptamine (DMT), plus β-carboline alkaloids with monoamine-oxidase-inhibiting properties. Acute administration induces an introspective dream-like experience characterized by visions and autobiographic and emotional memories. Studies of long-term users have suggested its therapeutic potential, reporting that its use has helped individuals abandon the consumption of addictive drugs. Furthermore, recent open-label studies in patients with treatment-resistant depression found that a single ayahuasca dose induced a rapid antidepressant effect that was maintained weeks after administration. Here, we conducted an exploratory study of the psychological mechanisms that could underlie the beneficial effects of ayahuasca.Methods We assessed a group of 25 individuals before and 24 h after an ayahuasca session using two instruments designed to measure mindfulness capacities: The Five Facets Mindfulness Questionnaire (FFMQ) and the Experiences Questionnaire (EQ).Results Ayahuasca intake led to significant increases in two facets of the FFMQ indicating a reduction in judgmental processing of experiences and in inner reactivity. It also led to a significant increase in decentering ability as measured by the EQ. These changes are classic goals of conventional mindfulness training, and the scores obtained are in the range of those observed after extensive mindfulness practice.Conclusions The present findings support the claim that ayahuasca has therapeutic potential and suggest that this potential is due to an increase in mindfulness capacities.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00213-015-4162-0

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 58 references

Cited by

Sorted by citations

Items 101–200 of 209

Metadata

Authors
Soler, J., Elices, M., Franquesa, A., Barker, S., Friedlander, P., Feilding, A., Pascual, J. C., & Riba, J.
Affiliations
  • Universitat Autònoma de Barcelona (ES)
  • Louisiana State University (US)
  • Beckley Foundation (GB)
Venue
Psychopharmacology
Published
2015-11-27
Volume
233
Issue
5
Pages
823-829
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2173679640
Cited by
209
References
58
Citations by year
2026: 8 · 2025: 23 · 2024: 16 · 2023: 35 · 2022: 23 · 2021: 27 · 2020: 19 · 2019: 18 · 2018: 17 · 2017: 12 · 2016: 10
FWCI
16.12
Type
journal article
Language
en
Open access
closed
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
  • Social Sciences › Health › Religion, Spirituality, and Psychology
Keywords
ayahuasca, mindfulness, N,N-dimethyltryptamine, 5-HT2A receptor agonists, β-carbolines, decentering, psychedelic therapy, treatment-resistant depression
MeSH terms
Adult, Carbolines, Female, Humans, Judgment, Male, Middle Aged, Monoamine Oxidase Inhibitors, Plant Extracts, Surveys and Questionnaires, Serotonin Receptor Agonists, Banisteriopsis, Receptor, Serotonin, 5-HT2A, Mindfulness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review